Substrate
Topic

melanoma

1 stories related to this topic, newest first.

FDA Rejects Cancer Drug Candidate Lifileucel on Second Attempt After Prior ReviewSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science24 days ago

FDA Rejects Cancer Drug Candidate Lifileucel on Second Attempt After Prior Review

The U.S. Food and Drug Administration has rejected the cancer drug candidate lifileucel for the second time. The drug, developed by Iovance Biotherapeutics, targets advanced melanoma. This decision follows an earlier rejection in 2023 and involves issues with manufacturing and da…

ST
1 source